The NADPH oxidase NOX5 protects against apoptosis in ALK-positive anaplastic large-cell lymphoma cell lines

Free Radical Biology and Medicine

Volumn 84, Issue , 2015, Pages 22-29

  Carnesecchi, S ^a   Rougemont, A L ^b   Doroshow, J H ^c   Nagy, M ^a   Mouche, S ^a   Gumy Pause, F ^d   Szanto, I ^a,b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Department of Pediatrics Hematology Oncology Unit CANSEARCH Research Laboratory   (Switzerland)

Author keywords

Anaplastic large cell lymphoma; Apoptosis; Free radicals; Karpas 299; NOX5; Reactive oxygen species

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; CASPASE 3; IONOMYCIN; MESSENGER RNA; NADPH OXIDASE NOX5; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SMALL INTERFERING RNA; SUPEROXIDE; THAPSIGARGIN; UNCLASSIFIED DRUG; MEMBRANE PROTEIN; NOX5 PROTEIN, HUMAN; PROTEIN TYROSINE KINASE;

ADOLESCENT; APOPTOSIS; ARTICLE; CASE REPORT; CELL PROLIFERATION; CHILD; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE SILENCING; GENETIC TRANSFECTION; GOLGI STAIN; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LARGE CELL LYMPHOMA; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; WESTERN BLOTTING; ENZYMOLOGY; GENE EXPRESSION; INFANT; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ADOLESCENT; APOPTOSIS; CELL LINE, TUMOR; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION; HUMANS; INFANT; LYMPHOMA, LARGE-CELL, ANAPLASTIC; MALE; MEMBRANE PROTEINS; NADPH OXIDASE; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 84928410839     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2015.02.027     Document Type: Article

References (62)

1. A.J. Ferreri, S. Govi, S.A. Pileri, and K.J. Savage Anaplastic large cell lymphoma, ALK-positive Crit. Rev. Oncol. Hematol. 83 2012 293 302
2. A.J. Ferreri, S. Govi, S.A. Pileri, and K.J. Savage Anaplastic large cell lymphoma, ALK-negative Crit. Rev. Oncol. Hematol. 85 2013 206 215
3. H. Stein, D.Y. Mason, J. Gerdes, N. O'Connor, J. Wainscoat, G. Pallesen, K. Gatter, B. Falini, G. Delsol, and H. Lemke The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells Blood 66 1985 848 858
4. N.L. Harris, E.S. Jaffe, H. Stein, P.M. Banks, J.K. Chan, M.L. Cleary, G. Delsol, C. De Wolf-Peeters, B. Falini, and K.C. Gatter A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group Blood 84 1994 1361 1392
5. S.W. Morris, M.N. Kirstein, M.B. Valentine, K.G. Dittmer, D.N. Shapiro, D.L. Saltman, and A.T. Look Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma Science 263 1994 1281 1284
6. K. Pulford, S.W. Morris, and F. Turturro Anaplastic lymphoma kinase proteins in growth control and cancer J. Cell. Physiol. 199 2004 330 358
7. G. Inghirami, and S.A. Pileri Anaplastic large-cell lymphoma Semin. Diagn. Pathol. 28 2011 190 201
8. C. Fiorani, G. Vinci, S. Sacchi, G. Bonaccorsi, and T. Artusi Primary systemic anaplastic large-cell lymphoma (CD30+): advances in biology and current therapeutic approaches Clin. Lymphoma 2 2001 29 37
9. A. Barreca, E. Lasorsa, L. Riera, R. Machiorlatti, R. Piva, M. Ponzoni, I. Kwee, F. Bertoni, P.P. Piccaluga, S.A. Pileri, and G. Inghirami Anaplastic lymphoma kinase in human cancer J. Mol. Endocrinol. 47 2011 R11 23
10. R. Chiarle, J.Z. Gong, I. Guasparri, A. Pesci, J. Cai, J. Liu, W.J. Simmons, G. Dhall, J. Howes, R. Piva, and G. Inghirami NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors Blood 101 2003 1919 1927
11. F. Chang, J.T. Lee, P.M. Navolanic, L.S. Steelman, J.G. Shelton, W.L. Blalock, R.A. Franklin, and J.A. McCubrey Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy Leukemia 17 2003 590 603
12. R.Y. Bai, T. Ouyang, C. Miething, S.W. Morris, C. Peschel, and J. Duyster Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway Blood 96 2000 4319 4327
13. H. Sauer, W. Neukirchen, G. Rahimi, F. Grunheck, J. Hescheler, and M. Wartenberg Involvement of reactive oxygen species in cardiotrophin-1-induced proliferation of cardiomyocytes differentiated from murine embryonic stem cells Exp. Cell Res. 294 2004 313 324
14. K.H. Krause Tissue distribution and putative physiological function of NOX family NADPH oxidases Jpn. J. Infect. Dis. 57 2004 S28 29
15. G. Cheng, Z. Cao, X. Xu, E.G. van Meir, and J.D. Lambeth Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5 Gene 269 2001 131 140
16. J.D. Lambeth NOX enzymes and the biology of reactive oxygen Nat. Rev. Immunol. 4 2004 181 189
17. K. Bedard, and K.H. Krause The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology Physiol. Rev. 87 2007 245 313
18. K. Bedard, V. Jaquet, and K.H. Krause NOX5: from basic biology to signaling and disease Free Radic. Biol. Med. 52 2012 725 734
19. B. Banfi, G. Molnar, A. Maturana, K. Steger, B. Hegedus, N. Demaurex, and K.H. Krause A Ca2+-activated NADPH oxidase in testis, spleen, and lymph nodes J. Biol. Chem. 276 2001 37594 37601
20. S.S. Brar, Z. Corbin, T.P. Kennedy, R. Hemendinger, L. Thornton, B. Bommarius, R.S. Arnold, A.R. Whorton, A.B. Sturrock, T.P. Huecksteadt, M.T. Quinn, K. Krenitsky, K.G. Ardie, J.D. Lambeth, and J.R. Hoidal NOX5 NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells Am. J. Physiol. Cell Physiol. 285 2003 C353 369
21. A.S. Kamiguti, L. Serrander, K. Lin, R.J. Harris, J.C. Cawley, D.J. Allsup, J.R. Slupsky, K.H. Krause, and M. Zuzel Expression and activity of NOX5 in the circulating malignant B cells of hairy cell leukemia J. Immunol. 175 2005 8424 8430
22. C. Desjobert, M.H. Renalier, J. Bergalet, E. Dejean, N. Joseph, A. Kruczynski, J. Soulier, E. Espinos, F. Meggetto, J. Cavaille, G. Delsol, and L. Lamant MiR-29a down-regulation in ALK-positive anaplastic large cell lymphomas contributes to apoptosis blockade through MCL-1 overexpression Blood 117 2011 6627 6637
23. R. Schnell, S. Barth, V. Diehl, and A. Engert Hodgkin's disease. Future treatment strategies: fact or fiction? Bailliere's Clin. Haematol 9 1996 573 593
24. N.J. Philpott, A.J. Turner, J. Scopes, M. Westby, J.C. Marsh, E.C. Gordon-Smith, A.G. Dalgleish, and F.M. Gibson The use of 7-amino actinomycin D in identifying apoptosis: simplicity of use and broad spectrum of application compared with other techniques Blood 87 1996 2244 2251
25. S. Antony, Y. Wu, S.M. Hewitt, M.R. Anver, D. Butcher, G. Jiang, J.L. Meitzler, H. Liu, A. Juhasz, J. Lu, K.K. Roy, and J.H. Doroshow Characterization of NADPH oxidase 5 expression in human tumors and tumor cell lines with a novel mouse monoclonal antibody Free Radic. Biol. Med. 65 2013 497 508
26. D. Jagnandan, J.E. Church, B. Banfi, D.J. Stuehr, M.B. Marrero, and D.J. Fulton Novel mechanism of activation of NADPH oxidase 5: calcium sensitization via phosphorylation J. Biol. Chem. 282 2007 6494 6507
27. B. Banfi, F. Tirone, I. Durussel, J. Knisz, P. Moskwa, G.Z. Molnar, K.H. Krause, and J.A. Cox Mechanism of Ca2+ activation of the NADPH oxidase 5 (NOX5) J. Biol. Chem. 279 2004 18583 18591
28. Y. Zhan, B. van de Water, Y. Wang, and J.L. Stevens The roles of caspase-3 and bcl-2 in chemically-induced apoptosis but not necrosis of renal epithelial cells Oncogene 18 1999 6505 6512
29. E.J. Lowe, and T.G. Gross Anaplastic large cell lymphoma in children and adolescents Pediatr. Hematol. Oncol. 30 2013 509 519
30. G.F. Perini, and B. Pro Brentuximab vedotin in CD30+ lymphomas Biol. Ther 3 2013 15 23
31. L. Mologni Inhibitors of the anaplastic lymphoma kinase Expert Opin. Invest. Drugs 21 2012 985 994
32. C.M. Lovly, and W. Pao Escaping ALK inhibition: mechanisms of and strategies to overcome resistance Sci. Transl. Med 4 2012 120ps2
33. R. Katayama, A.T. Shaw, T.M. Khan, M. Mino-Kenudson, B.J. Solomon, B. Halmos, N.A. Jessop, J.C. Wain, A.T. Yeo, C. Benes, L. Drew, J.C. Saeh, K. Crosby, L.V. Sequist, A.J. Iafrate, and J.A. Engelman Mechanisms of acquired crizotinib resistance in ALK-rearranged lung cancers Sci. Transl. Med 4 2012 120ra17
34. O. Merkel, F. Hamacher, E. Sifft, L. Kenner, and R. Greil Novel therapeutic options in anaplastic large cell lymphoma: molecular targets and immunological tools Mol. Cancer Ther. 10 2011 1127 1136
35. K. Block, and Y. Gorin Aiding and abetting roles of NOX oxidases in cellular transformation Nat. Rev. Cancer 12 2012 627 637
36. D. Pandey, A. Patel, V. Patel, F. Chen, J. Qian, Y. Wang, S.A. Barman, R.C. Venema, D.W. Stepp, R.D. Rudic, and D.J. Fulton Expression and functional significance of NADPH oxidase 5 (Nox5) and its splice variants in human blood vessels Am. J. Physiol. Heart Circ. Physiol 302 2012 H1919 1928
37. P. Yu, W. Han, V.A. Villar, Y. Yang, Q. Lu, H. Lee, F. Li, M.T. Quinn, J.J. Gildea, R.A. Felder, and P.A. Jose Unique role of NADPH oxidase 5 in oxidative stress in human renal proximal tubule cells Redox Biol 2 2014 570 579
38. A. El Jamali, A.J. Valente, J.D. Lechleiter, M.J. Gamez, D.W. Pearson, W.M. Nauseef, and R.A. Clark Novel redox-dependent regulation of NOX5 by the tyrosine kinase c-Abl Free Radic. Biol. Med. 44 2008 868 881
39. L. Ahmarani, L. Avedanian, J. Al-Khoury, C. Perreault, D. Jacques, and G. Bkaily Whole-cell and nuclear NADPH oxidases levels and distribution in human endocardial endothelial, vascular smooth muscle, and vascular endothelial cells Can. J. Physiol. Pharmacol. 91 2013 71 79
40. S.P. Hussain, L.J. Hofseth, and C.C. Harris Radical causes of cancer Nat. Rev. Cancer 3 2003 276 285
41. R.M. Sainz, F. Lombo, and J.C. Mayo Radical decisions in cancer: redox control of cell growth and death Cancers 4 2012 442 474
42. M.P. Oyarzo, E. Drakos, C. Atwell, H.M. Amin, L.J. Medeiros, and G.Z. Rassidakis Intrinsic apoptotic pathway in anaplastic large cell lymphoma Hum. Pathol. 37 2006 874 882
43. M.J. Arends, and A.H. Wyllie Apoptosis: mechanisms and roles in pathology Int. Rev. Exp. Pathol. 32 1991 223 254
44. G.M. Cohen Caspases: the executioners of apoptosis Biochem. J. 326 1997 1 16
45. M.G. Grutter Caspases: key players in programmed cell death Curr. Opin. Struct. Biol. 10 2000 649 655
46. S. Ueda, H. Masutani, H. Nakamura, T. Tanaka, M. Ueno, and J. Yodoi Redox control of cell death Antioxid. Redox Signaling 4 2002 405 414
47. M.L. Circu, and T.Y. Aw Reactive oxygen species, cellular redox systems, and apoptosis Free Radic. Biol. Med. 48 2010 749 762
48. S.J. Ralph, S. Rodriguez-Enriquez, J. Neuzil, E. Saavedra, and R. Moreno-Sanchez The causes of cancer revisited: mitochondrial malignancy and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy Mol. Aspects Med. 31 2010 145 170
49. J.L. Meitzler, S. Antony, Y. Wu, A. Juhasz, H. Liu, G. Jiang, J. Lu, K. Roy, and J.H. Doroshow NADPH oxidases: a perspective on reactive oxygen species production in tumor biology Antioxid. Redox Signaling 20 2014 2873 2889
50. K. Thornber, A. Colomba, L. Ceccato, G. Delsol, B. Payrastre, and F. Gaits-Iacovoni Reactive oxygen species and lipoxygenases regulate the oncogenicity of NPM-ALK-positive anaplastic large cell lymphomas Oncogene 28 2009 2690 2696
51. W. Zhang, T. McQueen, W. Schober, G. Rassidakis, M. Andreeff, and M. Konopleva Leukotriene B4 receptor inhibitor LY293111 induces cell cycle arrest and apoptosis in human anaplastic large-cell lymphoma cells via JNK phosphorylation Leukemia 19 2005 1977 1984
52. S. Dikalov Cross talk between mitochondria and NADPH oxidases Free Radic. Biol. Med. 51 2011 1289 1301
53. D. Suto, K. Sato, Y. Ohba, T. Yoshimura, and J. Fujii Suppression of the pro-apoptotic function of cytochrome c by singlet oxygen via a haem redox state-independent mechanism Biochem. J. 392 2005 399 406
54. K.J. Cho, J.M. Seo, and J.H. Kim Bioactive lipoxygenase metabolites stimulation of NADPH oxidases and reactive oxygen species Mol. Cells 32 2011 1 5
55. F. Chen, Y. Yu, S. Haigh, J. Johnson, R. Lucas, D.W. Stepp, and D.J. Fulton Regulation of NADPH oxidase 5 by protein kinase C isoforms PLoS One 9 2014 e88405
56. D. Pandey, and D.J. Fulton Molecular regulation of NADPH oxidase 5 via the MAPK pathway Am. J. Physiol. Heart Circ. Physiol 300 2011 H1336 1344
57. S. Orrenius, B. Zhivotovsky, and P. Nicotera Regulation of cell death: the calcium-apoptosis link Nat. Rev. Mol. Cell Biol. 4 2003 552 565
58. G. Hubinger, I. Scheffrahn, E. Muller, R. Bai, J. Duyster, S.W. Morris, H. Schrezenmeier, and L. Bergmann The tyrosine kinase NPM-ALK, associated with anaplastic large cell lymphoma, binds the intracellular domain of the surface receptor CD30 but is not activated by CD30 stimulation Exp. Hematol. 27 1999 1796 1805
59. M.J. Berridge Inositol trisphosphate and calcium signalling Nature 361 1993 315 325
60. R. Rust, L. Visser, J. van der Leij, G. Harms, T. Blokzijl, J.C. Deloulme, P. van der Vlies, W. Kamps, K. Kok, M. Lim, S. Poppema, and A. van den Berg High expression of calcium-binding proteins, S100A10, S100A11 and CALM2 in anaplastic large cell lymphoma Br. J. Haematol. 131 2005 596 608
61. B. Hallberg, and R.H. Palmer Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology Nat. Rev. Cancer 13 2013 685 700
62. Sibon et al., JCO 2012.